Coronavirus Vaccine Trial
- All
- News
- Videos
-
AstraZeneca Claims Positive Medicine Trial For "Severe" Covid
A treatment for people at risk of death from coronavirus has revealed good results in a late-stage trial, its maker AstraZeneca announced Wednesday.
-
US Health Regulator Lifts Hold On Covaxin's Clinical Trials
The US Food and Drug Administration which has put on hold phase 2/ 3 clinical trials of Bharat Biotech's COVID-19 vaccine Covaxin, in USA, has lifted pause, according to a statement issued by Ocugen Inc, Bharat Biotech's partner for jab in US, Canada
-
Wanted: Volunteers To Catch Covid In The Name Of Science
The world's first medical trial authorised to deliberately expose participants to the coronavirus is seeking more volunteers as it steps up efforts to help develop better vaccines.
-
Fourth Covid Vaccine "Partially" Effective Against Omicron: Study
Fourth doses of the Pfizer and Moderna vaccines against Covid-19 are only "partially" effective for the Omicron variant of the virus, the authors of an Israeli trial said Monday.
-
Needle-Free Air-Powered Covid Vaccine Trial Begins In UK
Scientists at the University of Cambridge on Tuesday began a clinical trial of a needle-free air-powered vaccine, which is expected to help combat future variants of COVID-19.
-
Vladimir Putin Says He Took Part In Trials Of Nasal Form Of Covid Vaccine
Russia said on Wednesday it planned to export a nasal form of its Sputnik vaccine against COVID-19, which President Vladimir Putin said he had taken as a booster.
-
Pfizer's Covid Vaccine Trial Data Shows Long-Term Efficacy In Adolescents
Pfizer Inc said on Monday its COVID-19 vaccine provided strong long-term protection against the virus in a late-stage study conducted among adolescents aged 12 to 15 years.
-
Pfizer Allows Others To Make Its Covid Pill, 53% Of The World To Benefit
US pharmaceutical giant Pfizer on Tuesday announced a deal to make its oral antiviral Covid-19 medication available more cheaply in poorer countries, if it passes trials and regulatory approval.
-
Trials For Covid Vaccine Pill To Begin In South Africa
South Africa has approved a clinical trial for a Covid vaccine pill, Israeli pharmaceutical company Oramed said on Friday.
-
Biological E Seeks Regulator's Nod For Phase-3 Trial Of Booster Dose
Biological E has sought permission from India's drug regulator to conduct the phase-3 clinical trial for its COVID-19 vaccine Corbevax as a single booster dose for those who have been fully vaccinated with Covishield or Covaxin.
-
AstraZeneca Claims Positive Medicine Trial For "Severe" Covid
A treatment for people at risk of death from coronavirus has revealed good results in a late-stage trial, its maker AstraZeneca announced Wednesday.
-
US Health Regulator Lifts Hold On Covaxin's Clinical Trials
The US Food and Drug Administration which has put on hold phase 2/ 3 clinical trials of Bharat Biotech's COVID-19 vaccine Covaxin, in USA, has lifted pause, according to a statement issued by Ocugen Inc, Bharat Biotech's partner for jab in US, Canada
-
Wanted: Volunteers To Catch Covid In The Name Of Science
The world's first medical trial authorised to deliberately expose participants to the coronavirus is seeking more volunteers as it steps up efforts to help develop better vaccines.
-
Fourth Covid Vaccine "Partially" Effective Against Omicron: Study
Fourth doses of the Pfizer and Moderna vaccines against Covid-19 are only "partially" effective for the Omicron variant of the virus, the authors of an Israeli trial said Monday.
-
Needle-Free Air-Powered Covid Vaccine Trial Begins In UK
Scientists at the University of Cambridge on Tuesday began a clinical trial of a needle-free air-powered vaccine, which is expected to help combat future variants of COVID-19.
-
Vladimir Putin Says He Took Part In Trials Of Nasal Form Of Covid Vaccine
Russia said on Wednesday it planned to export a nasal form of its Sputnik vaccine against COVID-19, which President Vladimir Putin said he had taken as a booster.
-
Pfizer's Covid Vaccine Trial Data Shows Long-Term Efficacy In Adolescents
Pfizer Inc said on Monday its COVID-19 vaccine provided strong long-term protection against the virus in a late-stage study conducted among adolescents aged 12 to 15 years.
-
Pfizer Allows Others To Make Its Covid Pill, 53% Of The World To Benefit
US pharmaceutical giant Pfizer on Tuesday announced a deal to make its oral antiviral Covid-19 medication available more cheaply in poorer countries, if it passes trials and regulatory approval.
-
Trials For Covid Vaccine Pill To Begin In South Africa
South Africa has approved a clinical trial for a Covid vaccine pill, Israeli pharmaceutical company Oramed said on Friday.
-
Biological E Seeks Regulator's Nod For Phase-3 Trial Of Booster Dose
Biological E has sought permission from India's drug regulator to conduct the phase-3 clinical trial for its COVID-19 vaccine Corbevax as a single booster dose for those who have been fully vaccinated with Covishield or Covaxin.
